New California Law Requires Posted Notices of Non-FDA Approved Stem Cell Products – Regulatory Focus
Regulatory Focus |
New California Law Requires Posted Notices of Non-FDA Approved Stem Cell Products
Regulatory Focus California's SB 512, which requires any health provider administering non-FDA approved stem cell treatments to post a notice and provide a handout about how the procedure has not been approved by FDA, also would impose maximum fines of $1,000 for … |
